FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

5599111000001105: Mesalazine 500mg modified-release tablets 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22871301000001115 Mesalazine 500mg modified-release tablets 50 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22871401000001111 Mesalazine 500mg modified-release tablets 50 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mesalazine 500mg modified-release tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Is pack of Mesalazine 500mg m/r tablet false Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Has active ingredient Mesalazine false Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Has VMP Mesalazine 500mg modified-release tablets true Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Has VMP Mesalazine 500mg m/r tablet false Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mesalazine 500mg modified-release tablets 50 tablet Has VMP Mesalazine 500mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pentasa 500mg modified-release tablets (PI) (Dowelhurst Ltd) 50 tablet 5 x 10 tablets Is a True Mesalazine 500mg modified-release tablets 50 tablet Inferred relationship Existential restriction modifier
Pentasa 500mg modified-release tablets (Sigma Pharmaceuticals Plc) 50 tablet Is a True Mesalazine 500mg modified-release tablets 50 tablet Inferred relationship Existential restriction modifier
Pentasa 500mg modified-release tablets (Waymade Healthcare Plc) 50 tablet Is a True Mesalazine 500mg modified-release tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start